Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.
Already, based on research about DNA repair, drugs called PARP inhibitors have been approved by the FDA for use in breast and ovarian cancers caused by BRCA mutations.
"Mammography might not be appropriate for use in breast cancer screening because it cannot distinguish between progressive and nonprogressive cancer," she said.
A variety of saline and silicone implants have been introduced over the years to optimize the shape, aesthetic result and safety profile for use in breast surgery.
That threatens to embroil the use of Avastin for ovarian cancer in a debate similar to the one surrounding its use in breast cancer.
To date, the only widely accepted markers for routine use in breast cancer are the oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor, HER-2 (c-erbB2/neu).
The article states it is most likely that private insurers will refuse to cover the $88,000 cost of the drug, but that "Medicare, however, has said it would continue to pay for the drug's use in breast cancer".
Federal officials said on Friday that Medicare would still provide coverage for the drug's use in breast cancer, though the government plans to "monitor the issue and evaluate coverage options".
Conroy Sun, a postdoctoral fellow in the Image Guided Intervention Laboratory, has received a Breast Cancer Research Program (BCRP) Fellowship Award from the Department of Defense to support the development and research of x-ray luminescent nanophosphors for use in breast tumor detection and treatment.
Recent advancements in dedicated gamma camera technology to permit imaging at low radiation doses now allow consideration of their use in breast cancer screening.
Bevacizumab is FDA-approved for the treatment of several tumor types but was approved then unapproved by the FDA for use in breast cancer due to a lack of evidence for its efficacy justifying its use.
